Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5551
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML ; volume:36 ; number:10 ; day:2 ; month:9 ; year:2022 ; pages:2418-2429 ; date:10.2022
Leukemia ; 36, Heft 10 (2.9.2022), 2418-2429, 10.2022
- Urheber
-
Allert, Catana
Waclawiczek, Alexander
Zimmermann, Sarah Miriam Naomi
Göllner, Stefanie
Heid, Daniel
Janssen, Maike
Renders, Simon
Rohde, Christian
Bauer, Marcus
Bruckmann, Margarita
Zinz, Rafael
Pauli, Cornelius
Besenbeck, Birgit
Wickenhauser, Claudia
Trumpp, Andreas
Krijgsveld, Jeroen
Müller-Tidow, Carsten
Blank, Maximilian Felix
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-022-01687-x
- URN
-
urn:nbn:de:101:1-2022121709100301637524
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Allert, Catana
- Waclawiczek, Alexander
- Zimmermann, Sarah Miriam Naomi
- Göllner, Stefanie
- Heid, Daniel
- Janssen, Maike
- Renders, Simon
- Rohde, Christian
- Bauer, Marcus
- Bruckmann, Margarita
- Zinz, Rafael
- Pauli, Cornelius
- Besenbeck, Birgit
- Wickenhauser, Claudia
- Trumpp, Andreas
- Krijgsveld, Jeroen
- Müller-Tidow, Carsten
- Blank, Maximilian Felix
- SpringerLink (Online service)
Ähnliche Objekte (12)
Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD
Editorial: Targeting bruton tyrosine kinase
Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer
Newer Tyrosine Kinase Inhibitors for CML
Second-generation inhibitors of Bruton tyrosine kinase
Targeting tumour microenvironment by tyrosine kinase inhibitor
Bcr-Abl tyrosine kinase inhibitors- current status
Auto-thiophosphorylation activity of Src tyrosine kinase
VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
Receptor tyrosine kinase activation in human carcinoma cells
An inducible tyrosine kinase receptor for axonal regeneration
Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD
Editorial: Targeting bruton tyrosine kinase
Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer
Newer Tyrosine Kinase Inhibitors for CML
Second-generation inhibitors of Bruton tyrosine kinase
Targeting tumour microenvironment by tyrosine kinase inhibitor
Bcr-Abl tyrosine kinase inhibitors- current status
Auto-thiophosphorylation activity of Src tyrosine kinase
VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
Receptor tyrosine kinase activation in human carcinoma cells
An inducible tyrosine kinase receptor for axonal regeneration
Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD
Editorial: Targeting bruton tyrosine kinase
Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer
Newer Tyrosine Kinase Inhibitors for CML
Second-generation inhibitors of Bruton tyrosine kinase
Targeting tumour microenvironment by tyrosine kinase inhibitor
Bcr-Abl tyrosine kinase inhibitors- current status
Auto-thiophosphorylation activity of Src tyrosine kinase
VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
Receptor tyrosine kinase activation in human carcinoma cells